Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2011 (2011), Article ID 174689, 10 pages
http://dx.doi.org/10.1155/2011/174689
Research Article

Age-Related Increase in the Number of Oligodendrocytes Is Dysregulated in Schizophrenia and Mood Disorders

Laboratory of Clinical Neuropathology, Mental Health Research Center, Moscow 115522, Russia

Received 14 January 2011; Accepted 1 April 2011

Academic Editor: Haiyun Xu

Copyright © 2011 Victor Vostrikov and Natalya Uranova. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Weinberger and B. K. Lipska, “Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground,” Schizophrenia Research, vol. 16, no. 2, pp. 87–110, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Haroutunian and K. L. Davis, “Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia,” International Journal of Neuropsychopharmacology, vol. 10, no. 4, pp. 499–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. K. L. Davis, D. G. Stewart, J. I. Friedman et al., “White matter changes in schizophrenia evidence for myelin-related dysfunction,” Archives of General Psychiatry, vol. 60, no. 5, pp. 443–456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. W. Flynn, D. J. Lang, A. L. Mackay et al., “Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins,” Molecular Psychiatry, vol. 8, no. 9, pp. 811–820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Dracheva, K. L. Davis, B. Chin, D. A. Woo, J. Schmeidler, and V. Haroutunian, “Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients,” Neurobiology of Disease, vol. 21, no. 3, pp. 531–540, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Hakak, J. R. Walker, C. Li et al., “Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4746–4751, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Bahn, “Gene expression in bipolar disorder and schizophrenia: new approaches to old problems,” Bipolar Disorders, vol. 4, no. 1, pp. 70–72, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Tkachev, M. L. Mimmack, M. M. Ryan et al., “Oligodendrocyte dysfunction in schizophrenia and bipolar disorder,” The Lancet, vol. 362, no. 9386, pp. 798–805, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Aston, L. Jiang, and B. P. Sokolov, “Microarray analysis of postmortem temporal cortex from patients with schizophrenia,” Journal of Neuroscience Research, vol. 77, no. 6, pp. 858–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Iwamoto, M. Bundo, K. Yamada et al., “DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia,” Journal of Neuroscience, vol. 25, no. 22, pp. 5376–5381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Katsel, K. L. Davis, and V. Haroutunian, “Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study,” Schizophrenia Research, vol. 79, no. 2-3, pp. 157–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Uranova, D. Orlovskaya, O. Vikhreva et al., “Electron microscopy of oligodendroglia in severe mental illness,” Brain Research Bulletin, vol. 55, no. 5, pp. 597–610, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. N. A. Uranova, V. M. Vostrikov, D. D. Orlovskaya, and V. I. Rachmanova, “Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium,” Schizophrenia Research, vol. 67, no. 2-3, pp. 269–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. V. M. Vostrikov, N. A. Uranova, and D. D. Orlovskaya, “Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders,” Schizophrenia Research, vol. 94, no. 1–3, pp. 273–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Buchsbaum, C. Y. Tang, S. Peled et al., “MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia,” NeuroReport, vol. 9, no. 3, pp. 425–430, 1998. View at Google Scholar · View at Scopus
  16. K. O. Lim, M. Hedehus, M. Moseley, A. de Crespigny, E. V. Sullivan, and A. Pfefferbaum, “Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging,” Archives of General Psychiatry, vol. 56, no. 4, pp. 367–374, 1999. View at Google Scholar · View at Scopus
  17. J. Foong, M. Maier, G. J. Barker, S. Brocklehurst, D. H. Miller, and M. A. Ron, “In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging,” Journal of Neurology Neurosurgery and Psychiatry, vol. 68, no. 1, pp. 70–74, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Foong, M. R. Symms, G. J. Barker et al., “Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging,” Brain, vol. 124, no. 5, pp. 882–892, 2001. View at Google Scholar · View at Scopus
  19. G. Bartzokis, K. H. Nuechterlein, P. H. Lu, M. Gitlin, S. Rogers, and J. Mintz, “Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study,” Biological Psychiatry, vol. 53, no. 5, pp. 412–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. D. D. Orlovskaya, V. M. Vostrikov, V. I. Rachmanova, and N. A. Uranova, “Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder, and major depression. (Abstracts of the “X biennial winter workshop on schizophrenia”, Davos, Switzerland, 2000),” Schizophrenia Research, vol. 41, pp. 105–106, 2000. View at Google Scholar
  21. V. M. Vostrikov, N. A. Uranova, V. I. Rakhmanova, and D. D. Orlovskaia, “Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia,” Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, vol. 104, no. 1, pp. 47–51, 2004. View at Google Scholar · View at Scopus
  22. P. R. Hof, V. Haroutunian, V. L. Friedrich et al., “Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia,” Biological Psychiatry, vol. 53, no. 12, pp. 1075–1085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Vostrikov, D. Orlovskaya, and N. Uranova, “Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia,” World Journal of Biological Psychiatry, vol. 9, no. 1, pp. 34–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Byne, A. Tatusov, G. Yiannoulos, G. S. Vong, and S. Marcus, “Effects of mental illness and aging in two thalamic nuclei,” Schizophrenia Research, vol. 106, no. 2-3, pp. 172–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. P. R. Huttenlocher, “Synaptic density in human frontal cortex: developmental changes and effects of aging,” Brain Research, vol. 163, no. 2, pp. 195–205, 1979. View at Publisher · View at Google Scholar · View at Scopus
  26. R. D. Terry, R. DeTeresa, and L. A. Hansen, “Neocortical cell counts in normal human adult aging,” Annals of Neurology, vol. 21, no. 6, pp. 530–539, 1987. View at Google Scholar · View at Scopus
  27. F. M. Benes, S. L. Vincent, and J. P. San Giovanni, “High resolution imaging of receptor binding an analyzing neurospychiatric diseases,” BioTechniques, vol. 7, no. 9, pp. 970–978, 1989. View at Google Scholar · View at Scopus
  28. F. M. Benes, M. Turtle, Y. Khan, and P. Farol, “Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood,” Archives of General Psychiatry, vol. 51, no. 6, pp. 477–484, 1994. View at Google Scholar · View at Scopus
  29. P. S. Qoldman-Rakic and L. D. Selemon, “Functional and anatomical aspects of prefrontal pathology in schizophrenia,” Schizophrenia Bulletin, vol. 23, no. 3, pp. 437–458, 1997. View at Google Scholar · View at Scopus
  30. J. N. Giedd, N. O. Jeffries, J. Blumenthal et al., “Childhood-onset schizophrenia: progressive brain changes during adolescence,” Biological Psychiatry, vol. 46, no. 7, pp. 892–898, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. H. J. Gundersen and E. B. Jensen, “The efficiency of systematic sampling in stereology and its prediction,” Journal of Microscopy, vol. 147, p. 3, 1987. View at Google Scholar · View at Scopus
  32. G. Rajkowska and P. S. Goldman-Rakic, “Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria,” Cerebral Cortex, vol. 5, no. 4, pp. 307–322, 1995. View at Google Scholar
  33. M. Polak, W. Haymaker, J. E. Johnson, and F. D'Amelio, “Neuroglia and their reactions,” in Histology and Histopathology of the Nervous System, W. Haymaker and R. D. Adams, Eds., pp. 363–480, Charles C. Thomas, Springfield, Ill, USA, 1982. View at Google Scholar
  34. H. J. G. Gundersen, T. F. Bendtsen, L. Korbo et al., “Some new, simple and efficient stereological methods and their use in pathological research and diagnosis,” APMIS, vol. 96, no. 5, pp. 379–394, 1988. View at Google Scholar · View at Scopus
  35. N. E. M. van Haren, W. Cahn, H. E. Hulshoff Pol, and R. S. Kahn, “Schizophrenia as a progressive brain disease,” European Psychiatry, vol. 23, no. 4, pp. 245–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. B. C. Ho, N. C. Andreasen, P. Nopoulos, S. Arndt, V. Magnotta, and M. Flaum, “Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia,” Archives of General Psychiatry, vol. 60, no. 6, pp. 585–594, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. L. R. Skelly, V. Calhoun, S. A. Meda, J. Kim, D. H. Mathalon, and G. D. Pearlson, “Diffusion tensor imaging in schizophrenia: relationship to symptoms,” Schizophrenia Research, vol. 98, no. 1–3, pp. 157–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. E. A. Hazlett, M. S. Buchsbaum, M. M. Haznedar et al., “Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients,” Schizophrenia Research, vol. 101, no. 1–3, pp. 111–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Rosenberger, M. Kubicki, P. G. Nestor et al., “Age-related deficits in fronto-temporal connections in schizophrenia: a diffusion tensor imaging study,” Schizophrenia Research, vol. 102, no. 1–3, pp. 181–188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Peters, “The effects of normal aging on myelinated nerve fibers in monkey central nervous system,” Frontiers in Neuroanatomy, vol. 3, p. 11, 2009. View at Google Scholar
  41. J. H. Sandell and A. Peters, “Effects of age on the glial cells in the rhesus monkey optic nerve,” Journal of Comparative Neurology, vol. 445, no. 1, pp. 13–28, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Peters and C. Sethares, “Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex,” Cerebral Cortex, vol. 14, no. 9, pp. 995–1007, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Peters, M. B. Moss, and C. Sethares, “Effects of aging on myelinated nerve fibers in monkey primary visual cortex,” Journal of Comparative Neurology, vol. 419, no. 3, pp. 364–376, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Bartzokis, M. Beckson, P. H. Lu et al., “Cortical gray matter volumes are associated with subjective responses to cocaine infusion,” American Journal on Addictions, vol. 13, no. 1, pp. 64–73, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Kubicki, C. F. Westin, P. G. Nestor et al., “Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study,” Biological Psychiatry, vol. 54, no. 11, pp. 1171–1180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. K. O. Lim, B. A. Ardekani, J. Nierenberg, P. D. Butler, D. C. Javitt, and M. J. Hoptman, “Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia,” American Journal of Psychiatry, vol. 163, no. 11, pp. 2008–2010, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. K. H. Karlsgodt, T. G. M. van Erp, R. A. Poldrack, C. E. Bearden, K. H. Nuechterlein, and T. D. Cannon, “Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia,” Biological Psychiatry, vol. 63, no. 5, pp. 512–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. P. G. Nestor, M. Kubicki, M. Niznikiewicz, R. J. Gurrera, R. W. McCarley, and M. E. Shenton, “Neuropsychological disturbance in schizophrenia: a diffusion tensor imaging study,” Neuropsychology, vol. 22, no. 2, pp. 246–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. P. R. Szeszko, D. G. Robinson, M. Ashtari et al., “Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia,” Neuropsychopharmacology, vol. 33, no. 5, pp. 976–984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Spoletini, A. Cherubini, M. Di Paola et al., “Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia,” Schizophrenia Research, vol. 108, no. 1–3, pp. 57–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. G. B. Frisoni, A. Prestia, A. Adorni et al., “In vivo neuropathology of cortical changes in elderly persons with schizophrenia,” Biological Psychiatry, vol. 66, no. 6, pp. 578–585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Molina, J. Sanz, F. Sarramea, C. Benito, and T. Palomo, “Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients,” Psychiatry Research, vol. 131, no. 1, pp. 45–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. G. R. Kuperberg, M. R. Broome, P. K. McGuire et al., “Regionally localized thinning of the cerebral cortex in schizophrenia,” Archives of General Psychiatry, vol. 60, no. 9, pp. 878–888, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Lopez-Garcia, H. J. Aizenstein, B. E. Snitz, R. P. Walter, and C. S. Carter, “Automated ROI-based brain parcellation analysis of frontal and temporal brain volumes in schizophrenia,” Psychiatry Research, vol. 147, no. 2-3, pp. 153–161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. D. C. Glahn, A. R. Laird, I. Ellison-Wright et al., “Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis,” Biological Psychiatry, vol. 64, no. 9, pp. 774–781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Kikinis, J. H. Fallon, M. Niznikiewicz et al., “Gray matter volume reduction in rostral middle frontal gyrus in patients with chronic schizophrenia,” Schizophrenia Research, vol. 123, no. 2-3, pp. 153–159, 2010. View at Publisher · View at Google Scholar
  57. J. S. Oh, M. Kubicki, G. Rosenberger et al., “Thalamo-frontal white matter alterations in chronic schizophrenia: a quantitative diffusion tractography study,” Human Brain Mapping, vol. 30, no. 11, pp. 3812–3825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Y. Tang, J. Friedman, D. Shungu et al., “Correlations between diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (H MRS) in schizophrenic patients and normal controls,” BMC Psychiatry, vol. 7, article 25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Dracheva, S. A. E. Marras, S. L. Elhakem, F. R. Kramer, K. L. Davis, and V. Haroutunian, “N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia,” American Journal of Psychiatry, vol. 158, no. 9, pp. 1400–1410, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Kanahara, E. Shimizu, Y. Sekine et al., “Does hypofrontality expand to global brain area in progression of schizophrenia? A cross-sectional study between first-episode and chronic schizophrenia,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 3, pp. 410–415, 2009. View at Publisher · View at Google Scholar
  61. H. P. Blumberg, J. H. Krystal, R. Bansal et al., “Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study,” Biological Psychiatry, vol. 59, no. 7, pp. 611–618, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. J. R. C. Almeida, A. Mechelli, S. Hassel, A. Versace, D. J. Kupfer, and M. L. Phillips, “Abnormally increased effective connectivity between parahippocampal gyrus and ventromedial prefrontal regions during emotion labeling in bipolar disorder,” Psychiatry Research, vol. 174, no. 3, pp. 195–201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. A. C. van der Schot, R. Vonk, R. M. Brouwer et al., “Genetic and environmental influences on focal brain density in bipolar disorder,” Brain, vol. 133, no. 10, pp. 3080–3092, 2010. View at Publisher · View at Google Scholar
  64. J. Savitz and W. C. Drevets, “Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide,” Neuroscience and Biobehavioral Reviews, vol. 33, no. 5, pp. 699–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. R. B. Sassi, J. A. Stanley, D. Axelson et al., “Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients,” American Journal of Psychiatry, vol. 162, no. 11, pp. 2109–2115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. C. M. Adler, J. Adams, M. P. DelBello et al., “Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study,” American Journal of Psychiatry, vol. 163, no. 2, pp. 322–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Rajkowska, “Cell pathology in bipolar disorder,” Bipolar Disorders, vol. 4, no. 2, pp. 105–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Öngür, W. C. Drevets, and J. L. Price, “Glial reduction in the subgenual prefrontal cortex in mood disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 13290–13295, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. C. J. Carter, “EIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?” Schizophrenia Bulletin, vol. 33, no. 6, pp. 1343–1353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Cotter, L. Hudson, and S. Landau, “Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia,” Bipolar Disorders, vol. 7, no. 4, pp. 358–369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. S. N. Mitkus, T. M. Hyde, R. Vakkalanka et al., “Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia,” Schizophrenia Research, vol. 98, no. 1–3, pp. 129–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. J. A. Frazier, J. L. Breeze, G. Papadimitriou et al., “White matter abnormalities in children with and at risk for bipolar disorder,” Bipolar Disorders, vol. 9, no. 8, pp. 799–809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Copray, J. L. Huynh, F. Sher, P. Casaccia-Bonnefil, and E. Boddeke, “Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging,” Glia, vol. 57, no. 15, pp. 1579–1587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. S. P. Mahadik and R. E. Scheffer, “Oxidative injury and potential use of antioxidants in schizophrenia,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 55, no. 1-2, pp. 45–54, 1996. View at Google Scholar · View at Scopus
  75. S. Y. Yao, A. Ljunggren-Rose, N. Chandramohan, W. O. Whetsell, and S. Sriram, “In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes,” Journal of Neuroimmunology, vol. 229, no. 1-2, pp. 146–156, 2010. View at Publisher · View at Google Scholar
  76. C. Matute, “Interaction between glutamate signalling and immune attack in damaging oligodendrocytes,” Neuron Glia Biology, vol. 3, no. 4, pp. 281–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Tebartz van Elst, G. Valerius, M. Büchert et al., “Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study,” Biological Psychiatry, vol. 58, no. 9, pp. 724–730, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. J. T. Coyle, “Glutamate and schizophrenia: beyond the dopamine hypothesis,” Cellular and Molecular Neurobiology, vol. 26, no. 4–6, pp. 365–384, 2006. View at Google Scholar · View at Scopus
  79. S. Prabakaran, J. E. Swatton, M. M. Ryan et al., “Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress,” Molecular Psychiatry, vol. 9, no. 7, p. 643, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. E. Courchesne, H. J. Chisum, J. Townsend et al., “Normal brain development and aging: qantitative analysis at in vivo MR imaging in healthy volunteers,” Radiology, vol. 216, no. 3, pp. 672–682, 2000. View at Google Scholar · View at Scopus
  81. G. Bartzokis, M. Beckson, P. H. Lu, K. H. Nuechterlein, N. Edwards, and J. Mintz, “Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study,” Archives of General Psychiatry, vol. 58, no. 5, pp. 461–465, 2001. View at Google Scholar · View at Scopus
  82. T. L. Jernigan and C. Fennema-Notestine, “White matter mapping is needed,” Neurobiology of Aging, vol. 25, no. 1, pp. 37–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Katsel, K. L. Davis, C. Li et al., “Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes,” Neuropsychopharmacology, vol. 33, no. 12, pp. 2993–3009, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Barley, S. Dracheva, and W. Byne, “Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder,” Schizophrenia Research, vol. 112, no. 1–3, pp. 54–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. R. S. Kern, J. M. Gold, D. Dickinson et al., “The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study,” Schizophrenia Research, vol. 126, no. 1–3, pp. 124–131, 2011. View at Publisher · View at Google Scholar
  86. G. T. Konopaske, K. A. Dorph-Petersen, R. A. Sweet et al., “Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys,” Biological Psychiatry, vol. 63, no. 8, pp. 759–765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. B.-C. Ho, N. C. Andreasen, S. Ziebell, R. Pierson, and V. Magnotta, “Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia,” Archives of General Psychiatry, vol. 68, no. 2, pp. 128–137, 2011. View at Publisher · View at Google Scholar
  88. J. Moncrieff and J. Leo, “A systematic review of the effects of antipsychotic drugs on brain volume,” Psychological Medicine, pp. 1–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Steiner, Z. Sarnyai, S. Westphal et al., “Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes,” European Archives of Psychiatry and Clinical Neuroscience. In press. View at Publisher · View at Google Scholar
  90. H. Wang, H. Xu, J. Niu et al., “Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain,” Schizophrenia Research, vol. 119, no. 1–3, pp. 164–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. B. D. Butts, C. Houde, and H. Mehmet, “Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease,” Cell Death and Differentiation, vol. 15, no. 7, pp. 1178–1186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Gritti, M. D. Molin, C. Foroni, and L. Bonfanti, “Effects of developmental age, brain region, and time in culture on long-term proliferation and multipotency of neural stem cell populations,” Journal of Comparative Neurology, vol. 517, no. 3, pp. 333–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. He, W. Cai, L. Wang, and P. Chen, “A developmental study on the expression of PDGFαR immunoreactive cells in the brain of postnatal rats,” Neuroscience Research, vol. 65, no. 3, pp. 272–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Reif, S. Fritzen, M. Finger et al., “Neural stem cell proliferation is decreased in schizophrenia, but not in depression,” Molecular Psychiatry, vol. 11, no. 5, pp. 514–522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. F. M. Benes, “The relationship between structural brain imaging and histopathologic findings in schizophrenia research,” Harvard Review of Psychiatry, vol. 1, no. 2, pp. 100–109, 1993. View at Google Scholar · View at Scopus
  96. S. Akbarian, J. J. Kim, S. G. Potkin, W. P. Hetrick, W. E. Bunney Jr., and E. G. Jones, “Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients,” Archives of General Psychiatry, vol. 53, no. 5, pp. 425–436, 1996. View at Google Scholar · View at Scopus
  97. N. Mellios, H. S. Huang, S. P. Baker, M. Galdzicka, E. Ginns, and S. Akbarian, “Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia,” Biological Psychiatry, vol. 65, no. 12, pp. 1006–1014, 2009. View at Publisher · View at Google Scholar · View at Scopus